LOGIN
OTA 2022: Long-Term Effect of Intra-operative Hip Fracture Injections on Pain and Function
October 2022
OTA 2022: Long-Term Effect of Intra-operative Hip Fracture Injections on Pain and Function
Study Type:Randomized Trial
OE Level Evidence:N/A
Journal Level of Evidence:N/A
The Long-Term Effect of Intraoperative Hip Fracture Injections (HiFI) on Function and Patient Reported Outcomes: A Randomized Controlled Trial
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
CONFERENCE ACE REPORTS
This ACE Report is a summary of a conference presentation or abstract. The information provided has limited the ability to provide an accurate assessment of the risk of bias or the overall quality. Please interpret the results with caution as trials may be in progress and select results may have been presented.
Synopsis
202 patients with hip fractures undergoing fracture fixation surgery were randomized to receive a multimodal pain injection to the fracture hematoma and operative site (n=82) or a no-injection control group (n=120). The primary outcomes of interest were inpatient pain levels, American Pain Society Patient Outcome Questionnaire (APS-POQ), ambulation distance, and length of stay. Secondary outcomes ...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.